Mml Investors Services, LLC Cara Therapeutics, Inc. Transaction History

Mml Investors Services, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.6 - $1.65 $9,705 - $26,690	-16,176 Reduced 16.55%	81,590 $61,000
Q3 2023 Nov 14, 2023	BUY	$1.67 - $3.33 $66,633 - $132,867	39,900 Added 68.95%	97,766 $164,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $41,221 - $71,956	14,566 Added 33.64%	57,866 $164,000
Q1 2023 May 12, 2023	BUY	$4.89 - $12.27 $9,716 - $24,380	1,987 Added 4.81%	43,300 $213,000
Q4 2022 Feb 13, 2023	SELL	$8.88 - $12.77 $16,285 - $23,420	-1,834 Reduced 4.25%	41,313 $444,000

Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $224,128 - $341,632	27,200 Added 170.56%	43,147 $404,000
Q2 2022 Aug 12, 2022	BUY	$7.45 - $13.84 $22,350 - $41,520	3,000 Added 23.17%	15,947 $146,000
Q1 2022 May 13, 2022	BUY	$9.94 - $12.65 $128,693 - $163,779	12,947 New	12,947 $157,000
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $281,213 - $425,455	-23,454 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $270,893 - $376,671	23,454 New	23,454 $362,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $17.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.